BP Publishes new Draft Texts
Recommendation
Dienstag, 23. Februar 2027 9 :00 - 17:00 Uhr
Integrating Compliance, Cost Transparency and Sustainable Value Creation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The British Pharmacopoeia (BP) has opened its next public consultation and feedback period for draft texts, covering 28 draft texts in total.
Six new monographs are included in this round:
- Naloxone Nasal Spray
- Rifampicin for Infusion
- Metronidazole Vaginal Gel
- Metronidazole Cream
- Memantine Oral Solution
- Hydrocortisone Tablets
The consultation also includes 22 revised draft texts:
- Thiotepa
- Thiotepa for Infusion
- Thiopental Injection
- Sodium fusidate ointment
- Rifampicin Oral Suspension
- Rifampicin Capsules
- Potassium Acetate Sterile Concentrate
- Perindopril Erbumine Tablets
- Oxazepam Tablets
- Metronidazole Oral Suspension
- Metronidazole Gel
- Furosemide Oral Solution
- Fluconazole Capsules
- Esomeprazole for Injection
- Cefuroxime for Injection
- Captopril Tablets
- Budesonide Pressurised Inhalation
- Budesonide Nebuliser Suspension
- Budesonide Inhalation Powder
- Budesonide Inhalation Powder, pre-metered
- Azathioprine Tablets
- Allopurinol Tablets
Comments can be submitted until 31 December 2026. All draft texts are available on the BP draft texts website , which also explains how to submit comments.
Related GMP News
19.10.2026EMA Updates Information Page on Bioequivalence Guidelines
19.10.2026FDA Identifies Critical Deficiencies in Analytical Testing and CGMP Oversight
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus
07.10.2026Pharmeuropa: Revision Proposed for Chapter 2.5.32 on Coulometric Karl Fischer Water Determination